Glenmark Life Sciences (GLS.NSE) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
7.63
8.95
10.27
11.6

Details

Expected EPS
10.19873744196
Actual EPS
11.598564149680001
Surprise EPS
1.4
Surprise Percent
+13.73%

Description

Glenmark Life Sciences (GLS.NSE) has reported earnings of 11.598564149680001 per share for Q2 2025.

0 Comments

Share your thoughts